MEDI-542

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMEDI-542
Drug Alias NameEphrin a4-targeting monoclonal antibody (MedImmune)MEDI-542
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionErythropoietin-producing hepatocellular receptor A4 blockers
TargetsErythropoietin-producing hepatocellular receptor A4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A